-
Johnson & Johnson is under fire again: New cancer lawsuits tied to its famous baby powder have jumped 17% after the company’s latest attempt at a global settlement collapsed in court.
-
American International Group is making a bold move — the insurance giant has struck a definitive deal to acquire the renewal rights to Everest Group’s $2 billion retail commercial business.
-
Four weeks into the U.S. government shutdown, the nation’s top disaster relief fund is on the brink of running dry, according to sources and an internal report obtained by Bloomberg.
-
Thousands of lawsuits, millions of pages of internal records, and endless hours of deposition transcripts are about to hit U.S. courtrooms — posing a serious threat to the future of the biggest social media giants.
-
In Florida, at least six property insurers are taking their fight with public adjusters to a new level — adding policy endorsements that all but tell homeowners: don’t hire them.
-
Tokio Marine Holdings Inc., Japan’s largest property and casualty insurer, is eyeing more than $10 billion in acquisitions to supercharge its global growth, according to Brad Irick, co-head of the company’s international operations.
-
For the second year in a row, Brightway Insurance in Ponte Vedra Beach, Florida, has earned a spot as a finalist on Insurance Journal’s Best Agencies to Work For – Southeast list.
-
Top executives at large firms are under pressure from a well-known ransomware gang that says it hacked into Oracle’s popular E-Business Suite and made off with their data, sources told Google’s cybersecurity team.
-
A hacker infiltrated the Federal Emergency Management Agency’s networks for months earlier this year, stealing sensitive data on FEMA and U.S. Customs and Border Protection employees, according to an incident report.
-
For decades, insurers have leaned on spreadsheets and aging legacy systems to handle one of their most vital tasks: pricing. But as market forces evolve and competitive pressures mount, those once-trusted tools are proving obsolete.
Johnson & Johnson is under fire again: New cancer lawsuits tied to its famous baby powder have jumped 17% after the company’s latest attempt at a global settlement collapsed in court.
